-
公开(公告)号:US20250163040A1
公开(公告)日:2025-05-22
申请号:US18779607
申请日:2024-07-22
Applicant: Cornell University
Inventor: John W. BABICH , Justin WILSON , Nikki THIELE , James KELLY , Shashikanth PONNALA
IPC: C07D413/14 , A61K45/06 , A61K51/04 , A61K51/10 , C07B59/00
Abstract: The present technology provides compounds as well as compositions including such compounds useful in targeted radiotherapy of cancer and/or mammalian tissue overexpressing prostate specific membrane antigen (“PSMA”) where the compounds are represented by the following: or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt thereof, wherein M1 is independently at each occurrence an alpha-emitting radionuclide. Equivalents of such compounds are also disclosed.
-
公开(公告)号:US12297157B2
公开(公告)日:2025-05-13
申请号:US16772706
申请日:2018-12-20
Applicant: Cornell University
Inventor: John W. Babich
Abstract: The present technology is directed to compounds, intermediates thereof, compositions thereof, medicaments thereof, and methods related to the imaging of mammalian tissue via 18F-labeled peptide ligands disclosed herein.
-
公开(公告)号:US20250145749A1
公开(公告)日:2025-05-08
申请号:US18685186
申请日:2022-08-19
Applicant: Cornell University
Inventor: Brett P. FORS , Scott SPRING , Tristan H. LAMBERT , Veronika KOTTISCH
IPC: C08F234/02 , C08F2/06
Abstract: Poly(cyclic vinyl ethers) (PCVEs), compositions of same, methods of making same, and uses of same. In various examples, PCVEs (e.g., homopolymers and/or copolymers) comprise repeat units comprising cyclic vinyl ether (CVE) groups in the backbone (e.g., poly(2,3-dihydrofuran) and/or poly(3,4-dihydropyran)). In various examples, PCVE homopolymers comprise molecular weights (Mn and/or Mw) of 200 kilodalton (kD) or greater. In various examples, PCVE copolymers (e.g., random or block) comprise one or more CVE group(s) and/or additional (e.g., acyclic vinyl ether (AVE) and/or styrenic) group(s)). A method of preparing PCVEs comprises polymerizing monomers comprising CVE groups (e.g., 2,3-dihydrofuran and/or 3,4-dihydropyran). In various examples, pentakis(carbonylcyclopentadienes) (PCCPs) and/or hydrogen bond donors are polymerization catalysts and/or initiators. various examples, PCVEs are biorenewable, recyclable, thermoplastic materials that exhibit desirable optical clarity, desirable barrier properties to, e.g., oxygen, carbon dioxide, and water, and find uses in food packaging, windows, and the like.
-
公开(公告)号:US20250144608A1
公开(公告)日:2025-05-08
申请号:US19011063
申请日:2025-01-06
Applicant: UCHICAGO ARGONNE, LLC , THE REGENTS OF THE UNIVERSITY OF CALIFORNIA , CORNELL UNIVERSITY , NORTHWESTERN UNIVERSITY , IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
Inventor: Massimiliano Delferro , Magali S. Ferrandon , Kenneth R. Poeppelmeier , Aaron D. Sadow , Susannah Scott , Anne M. LaPointe , Geoffrey Coates
Abstract: A method of upcycling polymers to useful hydrocarbon materials. A catalyst with nanoparticles on a substrate selectively docks and cleaves longer hydrocarbon chains over shorter hydrocarbon chains. The catalyst includes metal nanoparticles in an order array on a substrate.
-
公开(公告)号:US20250134888A1
公开(公告)日:2025-05-01
申请号:US18836654
申请日:2023-02-07
Inventor: Lewis Cantley , Costas Lyssiotis , Lin Lin , Mengrou Shan , Osamu Kaneko , Akio Kamikawa
IPC: A61K31/5025 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/519 , A61P35/00 , C07D213/69 , C07D401/06 , C07D471/04 , C07D487/04 , C07D519/00
Abstract: The present disclosure relates to compounds that inhibit malic enzyme 1. The disclosure further relates to methods of treating cancers mediated by malic enzyme 1.
-
公开(公告)号:US20250093341A1
公开(公告)日:2025-03-20
申请号:US18939959
申请日:2024-11-07
Applicant: CORNELL UNIVERSITY
Inventor: Francis BARANY , Eugene SPIER , Alain MIR
IPC: G01N33/53 , C12Q1/6806 , C12Q1/6813 , C12Q1/6851
Abstract: The present invention is directed to kits for identifying the presence of one or more target nucleotide sequences in a sample that involve a ligation and/or polymerase reaction. In some embodiments, the ligation products formed in the ligation process of the present invention are subsequently amplified using a polymerase chain reaction. The ligated product sequences or extension products thereof are detected, and the presence of one or more target nucleotide sequences in the sample is identified based on the detection.
-
公开(公告)号:US20250092067A1
公开(公告)日:2025-03-20
申请号:US18562243
申请日:2022-05-19
Applicant: Cornell University
Inventor: Hening Lin , Kevin Wielenberg , Min Yang
IPC: C07F5/02 , A61K31/496 , A61K31/675 , A61K31/69 , C07D409/06 , C07D495/04 , C07F9/6509 , C07F9/6558
Abstract: Compounds, compositions including one or more of the compound(s), and methods of using the compounds and the compositions. The compounds comprise an (I) group. In various examples, a compound is an Acyl Protein Thioesterase 1 inhibitor (APT1 inhibitor) and/or an Acyl Protein Thioesterase 2 inhibitor (APT2 inhibitor). Compound(s) or composition(s), which may be pharmaceutical composition(s), can be used in methods of treating diseases or disorders, such as, for example, autoimmune disorders, neurodegenerative disorders, inflammatory disorders, and immune-mediated cancer diseases.
-
公开(公告)号:US12255333B2
公开(公告)日:2025-03-18
申请号:US17711709
申请日:2022-04-01
Applicant: CORNELL UNIVERSITY
Inventor: Yong Lak Joo , Ling Fei
IPC: H01M4/587 , B05B5/03 , H01M4/04 , H01M4/13 , H01M4/139 , H01M4/36 , H01M4/38 , H01M4/48 , H01M4/485 , H01M4/62 , H01M10/0525 , H01M4/02
Abstract: Provided herein are high performance electrodes, electrode materials comprising a plurality of active electrode material-containing particles secured within one or more graphenic web, and precursors thereof. Also provided herein are processes of generating the same by an electrospray process.
-
9.
公开(公告)号:US20250088516A1
公开(公告)日:2025-03-13
申请号:US18897934
申请日:2024-09-26
Applicant: Cornell University
Inventor: Fan Zhang , Sai Krishna Deepak Maram , Harjasleen Malvai , Steven Goldfeder , Ari Juels
IPC: H04L9/40
Abstract: A verifier device in one embodiment is configured to communicate over one or more networks with a client device and a server device. The verifier device participates in a three-party handshake protocol with the client device and the server device in which the verifier device and the client device obtain respective shares of a session key of a secure session with the server device. The verifier device receives from the client device a commitment relating to the secure session with the server device, and responsive to receipt of the commitment, releases to the client device additional information relating to the secure session that was not previously accessible to the client device. The verifier device verifies correctness of at least one characterization of data obtained by the client device from the server device as part of the secure session, based at least in part on the commitment and the additional information.
-
公开(公告)号:US20250066746A1
公开(公告)日:2025-02-27
申请号:US18725018
申请日:2023-01-06
Applicant: CORNELL UNIVERSITY
Inventor: Matthew DELISA , Thapakorn JAROENTOMEECHAI , Dario MIZRACHI
IPC: C12N9/10 , C07K14/775 , C07K16/00 , C12N15/62
Abstract: The present disclosure relates to a nucleic acid construct having a chimeric nucleic acid molecule encoding a tripartite glycosyltransferase fusion protein. The chimeric nucleic acid molecule includes a first nucleic acid moiety encoding an amphipathic shield domain protein; a second nucleic acid moiety encoding a glycosyltransferase; and a third nucleic acid moiety encoding a water soluble expression decoy protein. The first nucleic acid moiety is coupled to the second nucleic acid moiety's 3′ end and the third nucleic acid moiety is coupled to the second nucleic acid moiety's 5′ end. The coupling may be direct or indirect. The present disclosure further relates to an expression vector, a host cell, and a tripartite glycosyltransferase fusion protein encoded by the nucleic acid construct. Also disclosed are methods of recombinantly producing a tripartite glycosyltransferase fusion protein in soluble form and methods of cell-free glycan remodeling.
-
-
-
-
-
-
-
-
-